Creating a cause of action for medical injuries resulting from the administration or prescription of gender transition surgery, cross-sex hormones, or puberty-blocking drugs and providing protections for individuals who receive medical detransitioning.
Impact
The bill, when enacted, will amend existing laws related to medical injuries in New Hampshire, particularly RSA 507-E. It introduces definitions and procedures specific to gender transition medical procedures, addressing concerns around informed consent and adverse medical outcomes. By providing a mechanism for legal recourse, the bill seeks to balance the rights of patients undergoing gender transition with the accountability of medical care providers, potentially leading to an increase in litigation related to these medical procedures.
Summary
Senate Bill 304 (SB304) aims to create a legal framework allowing individuals to file lawsuits for medical injuries resulting from gender transition treatments, which include surgeries, cross-sex hormones, and puberty-blocking drugs. It also establishes protections for individuals who undergo medical detransitioning from discrimination in healthcare settings. This bill is primarily focused on redefining medical liability in the context of gender-related medical care and emphasizes the rights of individuals who may wish to reverse their gender transition.
Sentiment
The sentiment surrounding SB304 is deeply polarized. Proponents argue that the bill is a necessary safeguard for individuals who may feel coerced into making irreversible medical decisions without sufficient knowledge of the consequences. They view it as a measure of personal autonomy and protection against potential negligence. Conversely, opponents assert that the bill promotes discrimination against transgender individuals and undermines established medical practices in gender-affirming care, raising concerns about stigmatization and access to necessary healthcare.
Contention
Notable points of contention include debates over the definitions of medical terms introduced in the bill, particularly surrounding gender identity and the nature of medically-induced injuries. Critics worry that the presumption of infertility as a liability could deter healthcare providers from offering gender-affirming treatments. Additionally, there are concerns about the broader implications this legislation may have on future access to care for transgender individuals and the potential chilling effect it may have on healthcare providers' willingness to engage in gender-affirming treatments.
Hospitals and Related Institutions; hormone therapies and puberty-blocking medications for certain purposes to minors; prohibit prescribing or administering
Protecting Minors from Medical Malpractice Act of 2025This bill makes a medical practitioner who performs a gender-transition procedure on an individual who is less than 18 years of age liable for any physical, psychological, emotional, or physiological harms from the procedure for 30 years after the individual turns 18.Additionally, if a state requires medical practitioners to perform gender-transition procedures, that state shall be ineligible for federal funding from the Department of Health and Human Services.Under the bill, gender-transition procedures generally include certain surgeries or hormone therapies that change the body of an individual to correspond to a sex that is discordant with the individual's biological sex. They exclude, however, interventions to treat (1) individuals who either have ambiguous external biological sex characteristics or lack a normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action; (2) infections, injuries, diseases, or disorders caused by a gender-transition procedure; or (3) a physical disorder, injury, or illness that places an individual in imminent danger of death or impairment of a major bodily function.